BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28680062)

  • 1. Linking functions: an additional role for an intrinsically disordered linker domain in the transcriptional coactivator CBP.
    Contreras-Martos S; Piai A; Kosol S; Varadi M; Bekesi A; Lebrun P; Volkov AN; Gevaert K; Pierattelli R; Felli IC; Tompa P
    Sci Rep; 2017 Jul; 7(1):4676. PubMed ID: 28680062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
    Dyson HJ; Wright PE
    J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
    Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
    J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
    Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
    Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
    Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral E1A Exploits Flexibility and Disorder to Target Cellular Proteins.
    Murrali MG; Felli IC; Pierattelli R
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33187345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in the Structural-Functional Characterization of Multidomain, Partially Disordered Proteins CBP and p300: Preparing Native Proteins and Developing Nanobody Tools.
    Bekesi A; Abdellaoui S; Holroyd N; Van Delm W; Pardon E; Pauwels J; Gevaert K; Steyaert J; Derveaux S; Borysik A; Tompa P
    Methods Enzymol; 2018; 611():607-675. PubMed ID: 30471702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112.
    Zucconi BE; Luef B; Xu W; Henry RA; Nodelman IM; Bowman GD; Andrews AJ; Cole PA
    Biochemistry; 2016 Jul; 55(27):3727-34. PubMed ID: 27332697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the CBP catalytic core in intramolecular SUMOylation and control of histone H3 acetylation.
    Park S; Stanfield RL; Martinez-Yamout MA; Dyson HJ; Wilson IA; Wright PE
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5335-E5342. PubMed ID: 28630323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
    Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
    J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
    Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
    J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational propensities of intrinsically disordered proteins influence the mechanism of binding and folding.
    Arai M; Sugase K; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9614-9. PubMed ID: 26195786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role for CBP and p300 CREB-binding domain in motor skill learning.
    Oliveira AM; Abel T; Brindle PK; Wood MA
    Behav Neurosci; 2006 Jun; 120(3):724-9. PubMed ID: 16768624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and molecular dynamics studies showed that CBP KIX mutation affects the stability of CBP:c-Myb complex.
    Odoux A; Jindal D; Tamas TC; Lim BW; Pollard D; Xu W
    Comput Biol Chem; 2016 Jun; 62():47-59. PubMed ID: 27082784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy.
    Gee CT; Koleski EJ; Pomerantz WC
    Angew Chem Int Ed Engl; 2015 Mar; 54(12):3735-9. PubMed ID: 25651535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300.
    Hyndman BD; Thompson P; Bayly R; Côté GP; LeBrun DP
    Biochim Biophys Acta; 2012 May; 1819(5):446-53. PubMed ID: 22387215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
    Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
    J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains.
    Wojciak JM; Martinez-Yamout MA; Dyson HJ; Wright PE
    EMBO J; 2009 Apr; 28(7):948-58. PubMed ID: 19214187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insight into the recognition of acetylated histone H3K56ac mediated by the bromodomain of CREB-binding protein.
    Xu L; Cheng A; Huang M; Zhang J; Jiang Y; Wang C; Li F; Bao H; Gao J; Wang N; Liu J; Wu J; Wong CCL; Ruan K
    FEBS J; 2017 Oct; 284(20):3422-3436. PubMed ID: 28815970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.